Lea M. Levi-Grote

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany.

Applying the 2024-revised McDonald criteria for multiple sclerosis using conventional diagnostic tools: a single-centre prospective cohort study in Germany.

Journal: EClinicalMedicine

Published: March 23, 2026

Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective Analysis.

Polyomavirus-Specific T Cells in Progressive Multifocal Leukoencephalopathy: A Multicenter Retrospective Analysis.

Journal: Transplantation and cellular therapy

Published: February 09, 2026

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.

Journal: JAMA neurology

Published: January 20, 2026

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Long-term prognosis of patients surviving progressive multifocal leukoencephalopathy.

Journal: Brain : a journal of neurology

Published: December 30, 2025

Virus-specific T-cell therapy for neuroinvasive West Nile virus.

Virus-specific T-cell therapy for neuroinvasive West Nile virus.

Journal: The Lancet. Neurology

Published: November 29, 2025

Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Discontinuation of ocrelizumab in multiple sclerosis: reoccurrence of disease activity.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: November 04, 2025

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

The Berlin-Hannover ICANS severity assessment-a novel bedside test to evaluate CAR T-cell-associated neurotoxicity.

Journal: Frontiers in neurology

Published: October 16, 2025

Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.

Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis.

Journal: Frontiers in neurology

Published: October 06, 2025

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Elevated C-Reactive Protein as a Potential Biomarker for Neurological Adverse Events in Immune Checkpoint Inhibitor Therapy: A Prospective Cohort Study.

Journal: Oncology research

Published: October 01, 2025

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Low triglyceride levels are associated with increased risk of immune-related adverse events in patients receiving immune checkpoint inhibitors.

Journal: Oncoimmunology

Published: August 16, 2025

Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entity.

Idiopathic inflammatory myopathy associated with Sjögren's disease: features of a distinct clinical entity.

Journal: Frontiers in immunology

Published: June 26, 2025

Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

Does Interrater Variation Influence the Classification According to the Diagnostic Criteria for Multiple Sclerosis?

Journal: European journal of neurology

Published: June 09, 2025

Showing 1-12 of 33

Last Updated: 09/26/2026